These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 10088196)

  • 41. Role of some vasoactive mediators in patients with erectile dysfunction: their relationship with angiotensin-converting enzyme and growth hormone.
    Hamed EA; Meki AR; Gaafar AA; Hamed SA
    Int J Impot Res; 2003 Dec; 15(6):418-25. PubMed ID: 14671660
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Increased plasma cyclic guanosine monophosphate concentrations in children with high levels of circulating atrial natriuretic peptide.
    Weil J; Gerzer R; Strom T; Lang RE; Döhlemann C; Knorr D; Bidlingmaier F
    Pediatrics; 1987 Oct; 80(4):545-8. PubMed ID: 2821478
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Limitations of compensation by endogenous atrial natriuretic peptide in heart failure.
    Tsutamoto T; Kanamori T; Wada A; Miyauchi N; Murata T; Kinoshita M
    Jpn Circ J; 1992 May; 56(5):489-93. PubMed ID: 1318429
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Presence of atrial natriuretic factor and cyclic guanosine monophosphate in saliva. Comparison of plasma and salivary concentrations during a head-down tilt.
    Gauquelin G; Maillet A; Allevard AM; Vorobiev D; Grigoriev AI; Gharib C
    Eur J Appl Physiol Occup Physiol; 1992; 65(1):25-9. PubMed ID: 1324176
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Atrial natriuretic peptide and cyclic guanosine-3',5'-monophosphate in normal and pathological pregnancies.
    Eckmann C; Hüneke B; Carstensen MH
    Gynecol Obstet Invest; 1990; 29(2):101-3. PubMed ID: 2159430
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effects of intraoperative administration of atrial natriuretic peptide.
    Hayashida N; Chihara S; Kashikie H; Tayama E; Yokose S; Akasu K; Aoyagi S
    Ann Thorac Surg; 2000 Oct; 70(4):1319-26. PubMed ID: 11081892
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Preexisting cardiopulmonary disease attenuating the atrial natriuretic peptide response. Results in patients with acute respiratory failure.
    Westendorp RG; Roos AN; Walma ST; Frölich M; Meinders AE
    Chest; 1992 Dec; 102(6):1758-63. PubMed ID: 1332838
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Neurohumoral mechanism in the natriuretic action of intracerebroventricular administration of renin.
    Zavala L; Barbella Y; Israel A
    J Renin Angiotensin Aldosterone Syst; 2004 Mar; 5(1):39-44. PubMed ID: 15136973
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Interactions of atrial and brain natriuretic peptides at pathophysiological levels in normal men.
    Hunt PJ; Espiner EA; Richards AM; Yandle TG; Frampton C; Nicholls MG
    Am J Physiol; 1995 Dec; 269(6 Pt 2):R1397-403. PubMed ID: 8594942
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Influence of blood pressure, heart rate, age, and sex on concentrations of atrial natriuretic factor and cyclic GMP in 124 volunteers.
    Wencker M; Hauptlorenz S; Moll W; Puschendorf B
    Clin Chem; 1989 Jul; 35(7):1519-23. PubMed ID: 2547532
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Possible regulation of renin release by ANP in dogs with heart failure.
    Kanamori T; Wada A; Tsutamoto T; Kinoshita M
    Am J Physiol; 1995 Jun; 268(6 Pt 2):H2281-7. PubMed ID: 7611478
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Atrial natriuretic peptide and blood volume in patients with chronic glomerulonephritis: effects of albumin and frusemide administration.
    Jespersen B; Danielsen H; Pedersen EB
    Nephrol Dial Transplant; 1990; 5(12):997-1006. PubMed ID: 1965738
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Influence of cardiopulmonary bypass on water balance hormones in children.
    Burch M; Lum L; Elliott M; Carter N; Slater D; Smith A; Ationu A
    Br Heart J; 1992 Sep; 68(3):309-12. PubMed ID: 1327039
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Angiotensin-converting enzyme inhibition prevents myocardial infarction-induced increase in renal cortical cGMP and cAMP phosphodiesterase activities.
    Clauss F; Charloux A; Piquard F; Doutreleau S; Talha S; Zoll J; Lugnier C; Geny B
    Fundam Clin Pharmacol; 2015 Aug; 29(4):352-61. PubMed ID: 25939307
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Plasma cyclic guanosine 3'-5' monophosphate concentrations and low vascular resistance in human septic shock.
    Schneider F; Lutun P; Couchot A; Bilbault P; Tempé JD
    Intensive Care Med; 1993; 19(2):99-104. PubMed ID: 8387555
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Atrial natriuretic peptide in severe primary and nonprimary pulmonary hypertension: response to iloprost inhalation.
    Wiedemann R; Ghofrani HA; Weissmann N; Schermuly R; Quanz K; Grimminger F; Seeger W; Olschewski H
    J Am Coll Cardiol; 2001 Oct; 38(4):1130-6. PubMed ID: 11583893
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The effect of volume expansion on atrial natriuretic peptide and cyclic guanosine monophosphate levels in young and aged subjects.
    Tan AC; Hoefnagels WH; Swinkels LM; Kloppenborg PW; Benraad TJ
    J Am Geriatr Soc; 1990 Nov; 38(11):1215-9. PubMed ID: 2174070
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Neurohormonal activation in patients with acute myocardial infarction or chronic congestive heart failure. With special reference to treatment with angiotensin converting enzyme inhibitors.
    Sigurdsson A
    Blood Press Suppl; 1995; 1():1-45. PubMed ID: 7599749
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of low dose infusions of ile-atrial natriuretic peptide in healthy elderly males: evidence for a postreceptor defect.
    Or K; Richards AM; Espiner EA; Yandle T; Gilchrist N; Sainsbury R
    J Clin Endocrinol Metab; 1993 May; 76(5):1271-4. PubMed ID: 8388403
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Kinetics of plasma cyclic GMP and atrial natriuretic peptide after intravenous, intramuscular and subcutaneous injection of 50 micrograms hANP in man.
    Osterode W; Nowotny P; Vierhapper H; Waldhäusl W
    Horm Metab Res; 1995 Feb; 27(2):100-3. PubMed ID: 7759055
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.